Anuh Pharma Share Price

Small Cap | Pharmaceuticals and health care | NSE: ANUHPHR | BSE: 506260

₹153.40 image-0.20 (-0.13 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 158.30

High (₹) 158.30

Low (₹) 153.25

Prev. Close (₹) 153.60

Volume 5,739

VWAP (₹) 155.24

ROCE (%) 26.84

Industry P/E 43.95

TTM P/E 15.29

P/B Ratio 2.64

Market Cap (₹) Cr.769.32

Dividend Yield (%)1.63

EPS (₹) 11.98

ROE20.62%

Sales Growth (%) 22.66

Profit Growth (%)66.00

Day Range

158.30158.30

L
H

52 Week Range

151.00265.00

L
H

Historical Returns

Returns (6M)

-28 %

Returns (1Y)

-32.6 %

Returns (3Y)

66.11 %

Returns (5Y)

164.8 %

Returns (6M)

-28 %

Returns (1Y)

-32.6 %

Returns (3Y)

66.11 %

Returns (5Y)

164.8 %

SWOT Analysis

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 11.84

MFI 13.25

ATR 7.18

Commodity Channel Index -96.00

ROC125 -23.84

ROC21 -20.81

Williams %R -99.04

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current157.19160.22161.94155.47152.44150.72147.69
Week Ago164.86166.58168.01163.43161.71160.28158.56
Month Ago197.06202.98206.61193.43187.51183.88177.96

EMA & SMA
info_icon

153.40

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 160.58


9 Day 161.33


10 Day 162.81


12 Day 166.79


14 Day 168.76

20 Day 178.39


26 Day 182.56


50 Day 198.64


100 Day 200.05


200 Day 211.51

Deals & Announcements

Bulk and Block Deals

No bulk or block deals available.

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
03 Sept, 2024BIJAL KAUSHAL SHROFFDisposal₹202.813,579BSE
03 Sept, 2024BIJAL KAUSHAL SHROFF RevisedDisposal₹202.602,521BSE
02 Sept, 2024BIJAL KAUSHAL SHROFFDisposal₹202.602,521BSE
27 Feb, 2024ROHAN MAHESH SHAHDisposal₹225.2610,000BSE
30 Jun, 2021BHARAT NEMCHAND SHAHDisposal10,000BSE
09 Jun, 2021Amisha Dipen KochaAcquisition20,500BSE
09 Jun, 2021Dina Satish ShahDisposal20,500BSE
31 May, 2021Bijal Kaushal ShroffDisposal₹126.5710,500BSE
02 Apr, 2021Kinjal Siddharth JhaveriAcquisition2,50,000BSE
02 Apr, 2021Surekha Bharat ShahDisposal1,00,000BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
17 May, 2024Rs.2.5000 per share(50%)Final Dividend16 Aug, 202401 Jan, 1970
19 May, 2023Rs.2.0000 per share(40%)Final Dividend11 Aug, 202301 Jan, 1970
16 May, 2022Rs.1.7500 per share(35%)Final Dividend03 Aug, 202201 Jan, 1970
07 Aug, 2020Bonus Issue in the ratio of 1:1 of Rs. 5/- each18 Sept, 202021 Sept, 2020

Announcements

DateSourceDetail
13 Feb, 2025NSE IndiaAnuh Pharma Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
13 Feb, 2025BSE IndiaNon-applicability of Statement of Deviation(s) and Variation(s) under Regulation 32(1), of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
11 Feb, 2025NSE IndiaAnuh Pharma Limited has informed the Exchange regarding Corrigendum to Unaudited Financial Results of the Company for the quarter ended 31st December, 2024 being published on 09th February, 2025, please find enclosed herewith the newspaper cutting for the corrigendum published in Mumbai Lakshdeep (Marathi Language) on 11th February, 2025
09 Feb, 2025NSE IndiaAnuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Un-audited financial results for the quarter ended 31st December, 2024, published in the Financial Express in English Language and Mumbai Lakhsdeep in Marathi Language on 09th February, 2025
07 Feb, 2025NSE IndiaIntegrated Filing - Financials for the Quarter ended 31st December, 2024
07 Feb, 2025BSE IndiaIntegrated Filing (Financial) for the Quarter ended 31st December, 2024
07 Feb, 2025NSE IndiaAnuh Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
07 Feb, 2025BSE IndiaUn-Audited Financial Results for the Quarter ended 31st December, 2024
07 Feb, 2025NSE IndiaAnuh Pharma Limited has informed the Exchange regarding Outcome of Board meeting held on February 07, 2025 with reference to Un-Audited Financial Results and Limited Review Report for the quarter ended 31st December, 2024
07 Feb, 2025BSE IndiaTo consider and approve the Un-audited Financial Results and Limited Review Report for the Quarter ended 31st December, 2024.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results & OthersTo consider other business matters.19 Feb, 202507 Feb, 2025
Quarterly Results--30 Oct, 202408 Nov, 2024
Quarterly Results--05 Aug, 202409 Aug, 2024
Audited Results & Final Dividend--10 May, 202417 May, 2024
Quarterly Results--05 Feb, 202409 Feb, 2024
Quarterly Results--03 Nov, 202310 Nov, 2023
Quarterly Results--07 Aug, 202311 Aug, 2023
Audited Results & Final Dividend--15 May, 202319 May, 2023
Quarterly Results--06 Feb, 202310 Feb, 2023
Quarterly Results--31 Oct, 202207 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Anuh Pharma

Anuh Pharma is a Public Limited Listed company incorporated on 19/02/1960 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1960PLC011586 and registration number is 011586. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 647.00 Cr. and Equity Capital is Rs. 25.06 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1960

Managing Director

Mr. Ritesh B Shah

NSE Symbol

ANUHPHR

Anuh Pharma Management

NameDesignation
Mr. Arun TodarwalChairman & Non-Exe.Director
Mr. Bipin N ShahVice Chairman
Mr. Ritesh B ShahJoint Managing Director
Mr. Vivek B ShahJoint Managing Director
Mr. Sandeep JoshiIndependent Director
Mr. Harmanbhai PatelIndependent Director
Dr.(Ms.) Mita DixitIndependent Director
Mr. Siddharth J ShahIndependent Director
Mr. Pradeep H ThakurIndependent Director
Mr. Ketan ShahNon Executive Director
Mr. Bharat ShahNon Executive Director
Mr. Samir ShahNon Executive Director
Mr. Gaurav S ShahNon Executive Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on Anuh Pharma

What is the share price of Anuh Pharma?

The share price of Anuh Pharma on 13 Mar, 2025 is ₹ 153.40.

What is 52W high and 52W low share price of Anuh Pharma?

The highest and lowest 52W share prices of Anuh Pharma are ₹ 265.000 and ₹ 151.000

What is the market cap of Anuh Pharma?

The market capitalization of Anuh Pharma as of 13 Mar, 2025 is ₹ 769.32 Crores

What is the P/E ratio of Anuh Pharma?

The current P/E ratio of Anuh Pharma as of 13 Mar, 2025 is 43.95

What is the PB ratio of Anuh Pharma?

The PB ratio of Anuh Pharma as of 13 Mar, 2025 is 2.64

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited